Earnings summaries and quarterly performance for MANULIFE FINANCIAL.
Executive leadership at MANULIFE FINANCIAL.
Board of directors at MANULIFE FINANCIAL.
Research analysts who have asked questions during MANULIFE FINANCIAL earnings calls.
Doug Young
Desjardins Capital Markets
6 questions for MFC
Gabriel Dechaine
National Bank Financial
6 questions for MFC
Mario Mendonca
TD Securities
6 questions for MFC
Paul Holden
CIBC World Markets
6 questions for MFC
Tom MacKinnon
BMO Capital Markets
6 questions for MFC
John Aiken
Jefferies Securities
5 questions for MFC
Lemar Persaud
Cormark Securities
4 questions for MFC
Alex Scott
Barclays PLC
3 questions for MFC
Meny Grauman
Scotiabank
3 questions for MFC
Darko Mihelic
RBC Capital Markets
2 questions for MFC
George Burmann
JP Turner and Company
2 questions for MFC
Gregg Abella
Investment Partners Asset Management
2 questions for MFC
Joe Pratt
Stifel
2 questions for MFC
David Erb
Merrion Investment Management
1 question for MFC
Graham Tanaka
Tanaka Capital Management
1 question for MFC
Nigel D'Souza
Veritas Investment Research
1 question for MFC
Rich Rogers
Abbey Capital
1 question for MFC
Thomas Gallagher
Evercore
1 question for MFC
Tony Pollock
Aegis Capital
1 question for MFC
William Meyers
Miller Asset Management
1 question for MFC
Recent press releases and 8-K filings for MFC.
- Manulife Financial Corporation (MFC) has entered into an underwriting agreement for the issuance of US$1,000,000,000 in 4.986% Senior Notes due 2035.
- The notes have a maturity date of December 11, 2035, and an interest rate (coupon) of 4.986% per annum.
- Interest payments will be made semi-annually on June 11 and December 11 of each year, commencing June 11, 2026.
- The closing date for this offering is December 11, 2025.
- The net proceeds to the company before expenses from this offering are US$995,500,000.
- Manulife Financial Corporation (MFC) priced a U.S. public offering of U.S.$1,000,000,000 aggregate principal amount of senior notes on December 2, 2025.
- The senior notes carry an interest rate of 4.986% and are due in 2035, with a public offering price of 100.000%.
- The company intends to use the net proceeds from the sale of these notes for general corporate purposes, which may include future refinancing requirements.
- Manulife Financial Corporation announced the pricing of a public offering in the United States of U.S.$1,000,000,000 aggregate principal amount of 4.986% senior notes due 2035.
- The notes were priced at 100%.
- The company intends to use the net proceeds from the sale of the notes for general corporate purposes, which may include future refinancing requirements.
- Manulife Financial's CFO discussed a refreshed strategy, aiming for 18%+ ROE by the end of 2027, building on a Q3 2025 normalized ROE of 17%.
- The company targets $1 billion in value creation from AI, driven by earnings increases from operational efficiency, Contractual Service Margin (CSM) growth, and cost avoidance.
- Manulife continues to pursue a balanced geographic strategy, with Asia remaining a key focus, targeting mid-teen core earnings growth and 21% ROE by 2027, and is entering the Indian insurance market.
- The company has been active in capital deployment, buying back $1.74 billion in shares year-to-date 2025, and is open to M&A opportunities in Canadian wealth, US retirement, and Asia distribution agreements.
- Manulife Financial has a refreshed strategy emphasizing geographic diversification, AI, distribution, people/culture, and health/wealth/longevity, shifting from a sole focus on Asia and GWAM.
- The company targets $1 billion in value creation from AI, primarily through operational efficiency, CSM growth, and cost avoidance, noting this will not necessarily be $1 billion in incremental earnings.
- Manulife maintains its mid-teen core earnings growth and 21% ROE targets for Asia by 2027, and plans to enter the Indian insurance market, expecting to sell policies in 12-18 months and break even in 3-4 years.
- The company has actively deployed capital, buying back 5% of stock last year and 3% this year, and holds $6 billion in excess capital and capacity. M&A strategy focuses on Canadian wealth, US retirement assets, and Asia distribution agreements, exemplified by the Comvest acquisition.
- Manulife is targeting an 18%+ ROE by the end of 2027, building from a Q3 2025 core ROE of 18.1% (normalized to 17%), with buybacks and normalized mortality as key levers.
- Manulife Financial has introduced a refreshed strategy to become a stable global champion, focusing on balancing growth across Canada, the U.S., Asia, and asset management, while emphasizing AI, distribution, people and culture, and health, wealth, and longevity.
- The company targets creating $1 billion in value from AI through earnings increases, CSM growth, and cost avoidance , and aims for an 18%+ Return on Equity (ROE) by the end of 2027, building on a Q3 ROE of 18.1% (normalized to 17%).
- Manulife has actively engaged in capital deployment, repurchasing $1.74 billion in shares year-to-date in 2025 and planning a 3% buyback this year, utilizing $6 billion in excess capital. The company's stance on M&A has shifted, with interest in Canadian wealth, US retirement, and Asia distribution agreements.
- Manulife is expanding into the Indian insurance market, anticipating 12-18 months before selling a policy and 3-4 years to break even.
- Under new CEO Phil Witherington, Manulife has launched a strategic refresh for a "new chapter" , with a key focus on becoming an AI-powered organization. This initiative is projected to generate $1 billion in benefits between 2025 and 2027, with approximately 20% derived from expense efficiency.
- The company plans to scale its US business beyond its niche high-net-worth segment, focusing on health, wellness, and longevity, with the US currently achieving a 15% return on equity and 40% new business value margins. This expansion will be supported by expense investment rather than capital injections and will avoid long-term guaranteed products.
- Manulife will invest in its Canadian operations, including insurance and wealth management, and has clarified that Manulife Bank is a core part of its proposition. The strategy aims to improve digital experiences and leverage global capabilities in the Canadian market.
- Capital allocation prioritizes organic investments, with 60%-70% of core earnings expected to translate to remittances to cover dividends, debt interest, and organic growth. Remaining capital will be deployed to share buybacks, with continuity expected in the near term, though a recent 4% reduction was elevated due to reinsurance transactions.
- Manulife emphasizes robust risk management and governance to reduce sensitivity to macro factors like interest rates and equity markets, aiming to anticipate and address challenges proactively.
- Manulife's new CEO, Phil Witherington, has implemented a strategic refresh to provide clarity and accelerate execution across the organization.
- The company is re-entering the Indian life insurance market through a 50/50 joint venture with Mahindra, aiming to establish a presence in all three "mega economies".
- Manulife's U.S. strategy is shifting to scale its health, wellness, and longevity offerings beyond its current niche, while avoiding long-term guaranteed products, with the U.S. business being highly capital accretive.
- Manulife is making significant investments in AI, with over 50 use cases in operation, projecting $1 billion in benefits between 2025 and 2027, primarily from revenue generation and policyholder experience improvements, with approximately 20% from expense efficiency.
- The company reaffirms its commitment to the Canadian market, including Manulife Bank, and plans to continue its share buyback program, which has led to a 4% reduction in share count over the past year.
- Manulife's new CEO, Phil Witherington, has launched a strategic refresh to position the company as a leading global life insurer and asset manager, emphasizing growth in key markets like the US, Canada, and a new joint venture in India.
- The company anticipates $1 billion in benefits from AI between 2025 and 2027, driven by productivity improvements, revenue generation, and expense efficiency.
- Manulife remains committed to share buybacks and robust risk management, aiming to reduce sensitivity to macro factors and ensure stable results.
- Manulife reported strong Q3 2025 financial results, with core EPS growing 16% from the prior year and a core ROE of 18.1%. High-potential businesses, Asia and global WAM, contributed 76% of core earnings year-to-date, exceeding the 2025 target.
- The company unveiled a refreshed enterprise strategy and announced a joint venture with Mahindra to enter the India insurance market, subject to regulatory approvals. This strategy emphasizes continued focus on Asia and global WAM, alongside deliberate investments in Canada and the U.S..
- Global Wealth and Asset Management (WAM) delivered record core earnings with a 9% year-on-year increase, despite experiencing $6.2 billion in net outflows during the quarter.
- Manulife maintains a strong balance sheet with a LICAT ratio of 138% and a leverage ratio of 22.7%, and expects approximately $6 billion in remittances for 2025.
Quarterly earnings call transcripts for MANULIFE FINANCIAL.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
Let Fintool AI Agent track MANULIFE FINANCIAL's earnings for you
Get instant analysis when filings drop